Evidence map›Paper›PMID 40803344›Full record

ArticleBritish journal of pharmacology2025

GCN2 regulates paclitaxel-induced neuropathic pain.

Alexander R Mikesell, Angela R Meyer, Guadalupe García, Luke R Frietze, Cheryl L Stucky, Tao Pan, Zachary T Campbell

Abstract read
In one paragraph

Article in British journal of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander R MikesellDepartment of Anesthesiology, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Angela R MeyerDepartment of Anesthesiology, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Guadalupe GarcíaDepartment of Anesthesiology, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Luke R FrietzeDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA.
Cheryl L StuckyDepartment of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Tao PanDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA.
Zachary T CampbellDepartment of Anesthesiology, University of Wisconsin - Madison, Madison, Wisconsin, USA.

Funding

Transcriptome-wide base-resolution sequencing of pseudouridine in human normal and AD brain tissues-CEGS Admin supplement 2020-2021RM1HG008935 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2016 to 2025
$24.4M
Pain Mechanisms in Fabry DiseaseR37NS108278 · NINDS · MEDICAL COLLEGE OF WISCONSIN · PI STUCKY, CHERYL LOUISE · 2019 to 2025
$5.6M
Profiling Translation in Nociceptor PlasticityR01NS114018 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Zachary Campbell · 2020 to 2026
$3.2M
NIH HHS R01NS114018NIH HHS R37 NS108278NIH HHS RM1HG008935NINDS NIH HHS R01 NS114018
6 · The paper itself

Abstract

background and purposeNeuropathic pain is debilitating and pervasive. Chemotherapeutic agents commonly induce chronic neuropathic pain. Paclitaxel is a prototypical example, causing painful peripheral neuropathy in a majority of patients. Paclitaxel triggers persistent changes in the excitability of sensory neurons resulting in hypersensitivity to sensory cues. The molecular mechanisms underlying paclitaxel-induced maladaptive plasticity are unclear. Here, we demonstrate a role for the Integrated Stress Response (ISR)-a key translational control mechanism-and its activating kinase, general control non-derepressible 2 kinase (GCN2), in paclitaxel-induced neuropathic pain (PINP). EXPERIMENTAL APPROACH: We used genetic and pharmacological techniques, including sensory neuron-specific GCN2 conditional knockout mice and the selective GCN2 inhibitor GCN2-IN-7. Behavioural assays assessed mechanical and cold hypersensitivity, while primary DRG neuron cultures were used to evaluate neuronal excitability via calcium imaging and protein translation by puromycin incorporation (surface sensing of translation, SUnSET). tRNA charging and abundance were measured using MSR-seq. KEY

resultsPaclitaxel robustly activated the ISR via GCN2 in mouse DRG sensory neurons, shown by increased eIF2α phosphorylation, elevated ATF4 levels and reduced global translation rates. Genetic deletion or pharmacological inhibition of GCN2 blocked paclitaxel-induced sensory neuron sensitisation and significantly attenuated mechanical and cold hypersensitivity in vivo. Mechanistically, paclitaxel reduced global tRNA charging and abundance in DRGs, providing a molecular basis for GCN2 activation. CONCLUSIONS AND IMPLICATIONS: These findings demonstrate that GCN2-dependent ISR activation is critical for PINP. Targeting GCN2 may represent a promising therapeutic strategy for preventing or alleviating chemotherapy-induced peripheral neuropathy, potentially improving patient quality of life and chemotherapy tolerance.

Indexed as

Antineoplastic Agents, PhytogenicNeuralgiaPaclitaxelProtein Serine-Threonine KinasesAnimalsCells, CulturedGanglia, SpinalMaleMiceMice, Inbred C57BLMice, KnockoutSensory Receptor CellsAntineoplastic Agents, PhytogenicEif2ak4 protein, mousePaclitaxelProtein Serine-Threonine KinaseseIF2GCN2ISRPINP

Identifiers

PMID40803344
PMCPMC12997401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.